文献速递重症综合管理与镇静镇痛儿科与产科急症

不同儿童危重症评分动态监测对体外膜氧合辅助休克治疗患儿预后的预测价值

[Prognostic value of dynamic monitoring of different pediatric critical illness scales in children with extracorporeal membrane oxygenation assisted shock treatment].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论对接受ECMO辅助治疗的难治性休克患儿,PCIS、PELOD-2和P-MODS评分在ECMO前及ECMO运行6小时、12小时均有预测院内死亡的价值,联合使用可提高预测效能。

该回顾性病例对照研究纳入2019年1月至2023年12月河南省儿童医院儿童心胸外科ICU收治的35例接受静脉-动脉ECMO辅助治疗的难治性休克患儿,计算ECMO前24小时、ECMO运行6小时和12小时的PCIS、PELOD-2和P-MODS评分。死亡组在ECMO前及ECMO运行各时间点的PCIS评分均低于存活组,PELOD-2评分均高于存活组;死亡组ECMO运行6小时和12小时的P-MODS评分高于存活组。ROC曲线分析显示,ECMO运行6小时和12小时的三种评分对院内死亡均有预测价值,其中6小时P-MODS和12小时PELOD-2预测准确性最高,三种评分联合使用预测价值更高,6小时联合AUC为0.809(95%CI 0.652-0.965),12小时联合AUC为0.892(95%CI 0.780-0.999)。

要点

  • 死亡组ECMO前24小时、运行6小时和12小时的PCIS评分均低于存活组(如12小时:77.76±1.35 vs. 85.00±1.53,P<0.05)。
  • 死亡组ECMO前24小时、运行6小时和12小时的PELOD-2评分均高于存活组(如12小时:8.00(7.00,13.50) vs. 6.00(5.00,8.00),P<0.05)。
  • 死亡组ECMO运行6小时和12小时的P-MODS评分高于存活组(6小时:7.94±0.52 vs. 5.61±0.55;12小时:5.29±0.71 vs. 3.22±0.44,均P<0.05)。
  • 三种评分联合预测院内死亡:ECMO运行6小时AUC 0.809(95%CI 0.652-0.965),敏感度83.33%、特异度70.59%;12小时AUC 0.892(95%CI 0.780-0.999),敏感度94.12%、特异度72.22%。
  • Hosmer-Lemeshow检验显示ECMO运行6小时P-MODS评分预测院内死亡拟合最佳(χ²=4.010,P=0.675),12小时PELOD-2评分拟合最佳(χ²=1.556,P=0.906)。

适用人群与场景

  • 2019年1月至2023年12月河南省儿童医院儿童心胸外科ICU收治的接受静脉-动脉ECMO辅助治疗的难治性休克患儿。

研究设计与关键结果

  • 回顾性病例对照研究,最终纳入35例接受ECMO辅助治疗的休克患儿,其中23例(66%)成功脱离ECMO,出院时存活18例(51%)、死亡17例(49%)。
  • 随着ECMO治疗时间延长,存活组和死亡组的PCIS评分均逐渐升高,PELOD-2和P-MODS评分均呈下降趋势。
  • 死亡组ECMO前24小时、运行6小时和12小时的PCIS评分均低于存活组(24小时前:72.00±1.87 vs. 78.22±1.87;6小时:75.53±2.15 vs. 81.89±1.35;12小时:77.76±1.35 vs. 85.00±1.53,均P<0.05)。
  • 死亡组ECMO前24小时、运行6小时和12小时的PELOD-2评分均高于存活组(24小时前:13.00(10.50,17.50) vs. 8.50(6.00,11.25);6小时:13.00(8.50,17.00) vs. 9.00(7.75,10.75);12小时:8.00(7.00,13.50) vs. 6.00(5.00,8.00),均P<0.05)。
  • 死亡组ECMO运行6小时和12小时的P-MODS评分高于存活组(6小时:7.94±0.52 vs. 5.61±0.55;12小时:5.29±0.71 vs. 3.22±0.44,均P<0.05)。
  • 两组间三种评分在ECMO运行6小时与12小时之间的差值差异无统计学意义。
  • ROC曲线分析显示,ECMO运行6小时和12小时的PCIS、PELOD-2、P-MODS评分对接受ECMO支持的休克患儿院内死亡均有预测价值;6小时P-MODS和12小时PELOD-2预测准确性最高;三种评分联合使用预测价值更高,6小时联合AUC为0.809(95%CI 0.652-0.965),敏感度83.33%、特异度70.59%;12小时联合AUC为0.892(95%CI 0.780-0.999),敏感度94.12%、特异度72.22%。
  • Hosmer-Lemeshow拟合优度检验显示,ECMO运行6小时P-MODS评分预测院内死亡拟合最佳(χ²=4.010,P=0.675),12小时PELOD-2评分预测死亡拟合最佳(χ²=1.556,P=0.906)。

证据类型、等级与局限

  • 证据类型:回顾性病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对接受ECMO辅助治疗的难治性休克患儿,可在ECMO前及ECMO运行6小时、12小时动态计算PCIS、PELOD-2和P-MODS评分,三种评分联合使用可能提高对院内死亡的预测价值、敏感度和特异度(作者结论)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the predictive value of different pediatric critical illness scores for the prognosis of children with refractory shock receiving extracorporeal membrane oxygenation (ECMO) auxiliary treatment.

METHODS: A retrospective case-control study was conducted. Pediatric patients admitted to the pediatric cardiac and thoracic surgery intensive care unit (ICU) at Henan Children's Hospital from January 2019 to December 2023 who received veno-arterial ECMO support for refractory shock were included. Clinical data were collected. The Pediatric Critical Illness Score (PCIS), PEdiatric Logistic Organ Dysfunction-2 (PELOD-2), and Pediatric Multiple Organ Dysfunction Score (P-MODS) were calculated based on vital signs and laboratory results at 24 hours before ECMO as well as 6 hours and 12 hours of ECMO. Pediatric patients were categorized into death and survival groups according to discharge outcomes. Differences in clinical data and the three scores between groups were compared. Receiver operator characteristic curve (ROC curve) analysis was used to assess the predictive value of the three scores for in-hospital death in ECMO-treated pediatric patients with shock. The Hosmer-Lemeshow goodness-of-fit test was used to evaluate the predictive accuracy of the three scoring systems for death.

RESULTS: A total of 35 pediatric patients with shock were ultimately included. Among them, 23 (66%) successfully weaned off ECMO. At discharge, 18 cases survived (51%), while 17 died (49%). As the duration of ECMO treatment increased, both the survival and death groups showed a gradual increase in PCIS scores, while PELOD-2 and P-MODS scores tended to decrease. Pediatric patients in the death group had lower PCIS scores than the survival group at all the time points before and on ECMO (24 hours before ECMO: 72.00±1.87 vs. 78.22±1.87, 6 hours of ECMO: 75.53±2.15 vs. 81.89±1.35, 12 hours of ECMO: 77.76±1.35 vs. 85.00±1.53, all P<0.05), and PELOD-2 scores were higher than those in the survival group [24 hours before ECMO: 13.00 (10.50, 17.50) vs. 8.50 (6.00, 11.25), 6 hours of ECMO: 13.00 (8.50, 17.00) vs. 9.00 (7.75, 10.75), 12 hours of ECMO: 8.00 (7.00, 13.50) vs. 6.00 (5.00, 8.00), all P<0.05]. Pediatric patients in the death group had higher P-MODS scores at 6 hours and 12 hours of ECMO as compared with the survival group (6 hours of ECMO: 7.94±0.52 vs. 5.61±0.55, 12 hours of ECMO: 5.29±0.71 vs. 3.22±0.44, both P<0.05). The differences in the three scores between 6 hours and 12 hours of ECMO were not statistically significant between groups. ROC curve analysis indicated that the PCIS, PELOD-2, P-MODS scores at 6 hours and 12 hours of ECMO had predictive value for in-hospital death in pediatric patients with shock receiving ECMO support. The 6-hour P-MODS score and 12-hour PELOD-2 score demonstrated the highest predictive accuracy, with combined use of all three scoring systems yielding greater predictive value, the area under the ROC curve (AUC) of 6 hours was 0.809 [95% confidence interval (95%CI) was 0.652-0.965], with sensitivities and specificities of 83.33% and 70.59%, respectively; the AUC of 12 hour was 0.892 (95%CI was 0.780-0.999), with sensitivities and specificities of 94.12% and 72.22%, respectively. The Hosmer-Lemeshow goodness-of-fit test indicated that the 6-hour P-MODS score of ECMO provided the best fit for predicting in-hospital death in pediatric patients with shock receiving ECMO support (χ 2=4.010, P=0.675), while the 12-hour PELOD-2 score of ECMO provided the best fit for predicting death (χ 2=1.556, P=0.906).

CONCLUSIONS: PCIS, PELOD-2, and P-MODS scores before and on ECMO demonstrated predictive value and good fit for predicting in-hospital death in children with shock receiving ECMO support, and allow for continuous dynamic monitoring. Combined use of these three scores further enhances predictive value, sensitivity, and specificity.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xue Y, Jia W, Zhang X, et al. [Prognostic value of dynamic monitoring of different pediatric critical illness scales in children with extracorporeal membrane oxygenation assisted shock treatment]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41833352. doi:10.3760/cma.j.cn121430-20241114-00933

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。